Monday, October 19, 2026
9:00-9:15 |
WELCOME AND OPENING REMARKS |
| Ted Fon, Director, The Neuro, McGill University | |
9:15-10:30 |
KEYNOTE PRESENTATION |
|
Scaling CRISPR Cures to 500 Inborn Errors of Immunity and Beyod   Fyodr Urnov – University of California, Berkeley Advanced Clinical Therapies in Clinical Research at The Neuro   Massimo Pandolfo + Ziv Gan-Or – The Neuro, McGill University, Montreal, QC Multi-institutional Collaboration in Developing Personalized Treatments   Navpreet Sangha + Stalinjeet Gill – SPG4 Hope Foundation |
|
10:30-11:00 |
Coffee Break |
11:00-12:15 |
GENE AND GENE-EDITING METHODS AND THERAPIES |
|
Base Editing in Rare Neurological Disorders   Jagdeep Walia – Queens University, Kingston, ON Non-Viral Genome Editing for Rare Genetic Disorders   Yong-Hui Jiang – Yale School of Medicine, New Haven, CT Gene Therapies for Oculopharyngeal Muscular Dystrophy (OPMD)   Guy Rouleau – Chair of Neurology, McGill University, Montreal, QC |
|
12:15-1:45 |
Lunch – Poster Session |
1:45-3:00 |
DEVELOPMENTS IN BRAIN DELIVERY METHODS |
|
Neurosurgical Advances to Treat Genetic Brain Disorders   Andres Lozano – University of Toronto, ON Small extracellular vesicle communication to deliver RNA therapies   Derrick Gibbings – University of Ottawa, ON MRI-Guided Focused Ultrasound in the Delivery of Therapeutics to the Brain   Isabelle Aubert – Sunnybrook Research Institute, Toronto, ON |
|
3:00-3:15 |
Coffee Break |
3:15-4:30 |
NOTES FROM A DECADE OF RNA THERAPEUTICS |
|
Lessons learned in Therapeutic development for pediatric neuromuscular disorders   Maryam Oskoui – CHU Ste-Justine Research Centre, Montreal, QC The development of Onpattro for the treatment of polyneuropathy in individuals with HATTR   Phillip Zamore – University of Massachusetts/ McGill University |
|
4:30-6:00 |
NETWORKING COCKTAIL |
GOLD SPONSORS
SILVER SPONSORS
BRONZE SPONSORS
